<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Implantation or Injectable Dosage Form New Animal Drugs; Danofloxacin</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Implantation or Injectable Dosage Form New Animal Drugs; Danofloxacin</h1>
    <p class="timestamp">Published: 2012-01-27 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Pfizer, Inc. The supplemental NADA provides for an additional dosage regimen for use of danofloxacin mesylate injectable solution for the treatment of bovine respiratory disease in beef cattle.</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Rule</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2012-1743</p>
    <p><strong>Publication Date:</strong> 2012-01-27</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2012/01/27/2012-1743/implantation-or-injectable-dosage-form-new-animal-drugs-danofloxacin">https://www.federalregister.gov/documents/2012/01/27/2012-1743/implantation-or-injectable-dosage-form-new-animal-drugs-danofloxacin</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2012-1743</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
